Skip to content

13F-HR filed by EMORY UNIVERSITY

EMORY UNIVERSITY filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-13, with 44 holding rows worth $116,540,000.

Accession
0001377635-18-000001
Filed
2018-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 44 entries on the cover page, a total value of $116,540,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $116,540,000 with VALUE read as thousands by filing date, 13F file number 028-16101. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BERKSHIRE HATHAWAY INC DEL084670108CL A117$34,819,000thousands by filing date
JD.COM INC SPON ADS CL A47215P106ADR124,440$5,154,000thousands by filing date
FOX CORP CLASS B90130A200COM65,055$2,220,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock63,013$2,212,000thousands by filing date
ARMSTRONG WORLD INDS INC NEW04247X102COM35,959$2,177,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM62,926$2,152,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR21,956$2,146,000thousands by filing date
TRINITY INDS INC896522109COM54,906$2,057,000thousands by filing date
BREAD FINANCIAL HOLDINGS INC018581108COM8,105$2,054,000thousands by filing date
AVEXIS INC05366U100COM18,474$2,045,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM67,758$2,040,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR50,813$2,036,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR81,916$2,015,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM74,378$2,007,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM16,773$2,006,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM170,404$2,004,000thousands by filing date
Morgan Stanley617446448COM37,911$1,989,000thousands by filing date
KKR & CO LP48248M102COMMON STOCK93,944$1,978,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM22,137$1,974,000thousands by filing date
SEAGATE TECHNOLOGY PLCG7945M107SHS47,154$1,973,000thousands by filing date
ZOGENIX INC.98978L204Common Stock48,843$1,956,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM135,364$1,948,000thousands by filing date
Microsoft Corp594918104COM22,655$1,938,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM24,945$1,935,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock383,768$1,884,000thousands by filing date
BAKER HUGHES COMPANY CL A05722G100Stock58,965$1,866,000thousands by filing date
ADVANCED ACCELERATOR APPLIC SPONSORED ADS00790T100ADR22,538$1,840,000thousands by filing date
CBRE GROUP INC CL A12504L109Stock42,266$1,831,000thousands by filing date
KALA BIO INC COM483119103Stock98,796$1,827,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock14,344$1,822,000thousands by filing date
SUMMIT MIDSTREAM PARTNERS LP866142102COM UNIT LTD87,560$1,795,000thousands by filing date
RETROPHIN INC761299106COM84,885$1,789,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM45,441$1,788,000thousands by filing date
SEATTLE GENETICS INC812578102COM31,683$1,695,000thousands by filing date
TESARO INC881569107COM20,407$1,691,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK17,044$1,685,000thousands by filing date
AVEO PHARMACEUTICALS INC053588109COM602,883$1,682,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 251,632$1,662,000thousands by filing date
MYOVANT SCIENCES LTDG637AM102COMMON STOCK-FO131,363$1,660,000thousands by filing date
CORIUM INTL INC21887L107COM168,053$1,615,000thousands by filing date
INCYTE CORP COM45337C102Stock17,046$1,614,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM518,223$1,492,000thousands by filing date
SPY78462F103SHS889$237,000thousands by filing date
Apple Inc037833100COM1,359$230,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001377635-18-000001this filing2018-02-13acceptance time not in the bulk data set